wire - news in brief
Category
Results 51 - 100 of 322.
Smart transportation systems need smart governance
Two EPFL researchers have just published a book highlighting the need for cities to adopt adequate governance mechanisms for their transportation systems.
Two EPFL researchers have just published a book highlighting the need for cities to adopt adequate governance mechanisms for their transportation systems.
Roche’s investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer
Entrectinib reduced tumours in people with ROS1-positive non-small cell lung cancer (NSCLC), including those whose disease had spread to the central nervous system (CNS) Data will be submitted to glo
Entrectinib reduced tumours in people with ROS1-positive non-small cell lung cancer (NSCLC), including those whose disease had spread to the central nervous system (CNS) Data will be submitted to glo
Sharing data online: an innovative solution to respect and protect privacy
Insights from research at HEC Lausanne-UNIL - While respect for privacy is increasingly undermined on the web by publishing and sharing personal data, the solution for web actors developed by Prof&pe
Insights from research at HEC Lausanne-UNIL - While respect for privacy is increasingly undermined on the web by publishing and sharing personal data, the solution for web actors developed by Prof&pe
Facts and figures on Switzerland’s participation in the European Framework Programmes for Research
Bern, 20.09.2018 - The State Secretariat for Education, Research and Innovation (SERI) today published a report on Switzerland's involvement in the eighth European Framework Programme for Research and Innovation (Horizon 2020; 2014-2020).
Bern, 20.09.2018 - The State Secretariat for Education, Research and Innovation (SERI) today published a report on Switzerland's involvement in the eighth European Framework Programme for Research and Innovation (Horizon 2020; 2014-2020).
Today, the University of Basel and ETH Zurich co-founded the Botnar Research Centre for Child Health (BRCCH) in Basel.
Banks Do too Little to Communicate Their Sustainable Investment Products
Less than one percent of the global population controls more than 50 percent of wealth. All over the world these wealthy investors have an increasing interest in investing their wealth sustainably, in accordance with socially responsible, environmentally friendly and ethical principles.
Less than one percent of the global population controls more than 50 percent of wealth. All over the world these wealthy investors have an increasing interest in investing their wealth sustainably, in accordance with socially responsible, environmentally friendly and ethical principles.
The Affinity Map showing cross-laboratory collaboration among faculty at EPFL's School of Architecture, Civil and Environmental Engineering (ENAC) is now available to the general public. One of its creators will soon be heading off to MIT on a grant to expand his idea to a global scale. Scientists around the world are excited about the new possibilities being offered by advanced data collection and processing methods.
Marie Heim-Vögtlin Prize 2018: Sara Montagner discovers the epigenetic secrets of mast cells
Epigenetic modifications of our DNA are a key aspect of the normal functioning of mast cells, which play an important role in immune reactions. Biologist Sara Montagner was able to demonstrate this in her work. She will receive this year's Marie Heim-Vögtlin Prize from the SNSF at the award ceremony in Bellinzona on 29 November 2018.
Epigenetic modifications of our DNA are a key aspect of the normal functioning of mast cells, which play an important role in immune reactions. Biologist Sara Montagner was able to demonstrate this in her work. She will receive this year's Marie Heim-Vögtlin Prize from the SNSF at the award ceremony in Bellinzona on 29 November 2018.
Clear mountain lakes could change with ever greater frequency into milky soup in the future. Climate change is the guilty agent.
University of Basel and ETH Zurich Combine Cutting-Edge Research for Children and Adolescents Worldwide
Today, the University of Basel and ETH Zurich co-founded the Botnar Research Centre for Child Health (BRCCH) in Basel.
Today, the University of Basel and ETH Zurich co-founded the Botnar Research Centre for Child Health (BRCCH) in Basel.
IRSP : Collection for the 30 years of publications
3 articles of UnilaPS are proposed in this collection of the International Review of Social Psychology With its first volume published in 1988, the International Review of Social Psychology (IRSP) is 30 years old this year (1988-2018). In this special occasion, they investigated the history of the journal in order to retrace its origin and evolution.
3 articles of UnilaPS are proposed in this collection of the International Review of Social Psychology With its first volume published in 1988, the International Review of Social Psychology (IRSP) is 30 years old this year (1988-2018). In this special occasion, they investigated the history of the journal in order to retrace its origin and evolution.
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya in children and adolescents with MS
Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs.
Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs.
Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx in daily life for psoriasis patients
Real-world evidence confirms Cosentyx efficacy and safety consistent with previously reported clinical studies - Novartis presents a large program of real-world evidence at the 27 th European Academy of Dermatology and Venereology (EADV) Congress, adding to the robust body of clinical data supporting the use of Cosentyx in moderate-to-severe psoriasis - Cosentyx 5-year data in psoriasis from a Phase III study were presented in 2017 , proving lon
Real-world evidence confirms Cosentyx efficacy and safety consistent with previously reported clinical studies - Novartis presents a large program of real-world evidence at the 27 th European Academy of Dermatology and Venereology (EADV) Congress, adding to the robust body of clinical data supporting the use of Cosentyx in moderate-to-severe psoriasis - Cosentyx 5-year data in psoriasis from a Phase III study were presented in 2017 , proving lon
Novartis survey shows psoriasis patients want treatment effect beyond clear skin
New patient preference survey confirms that patients value clear skin the most, but expect additional benefits from their treatment, such as proven long-term efficacy and safety data and no injection site reactions A separate ranking incorporating additional characteristics showed that effectiveness in treating multiple manifestations of psoriatic disease was also important The number of injections per dose and injection frequency were least imp
New patient preference survey confirms that patients value clear skin the most, but expect additional benefits from their treatment, such as proven long-term efficacy and safety data and no injection site reactions A separate ranking incorporating additional characteristics showed that effectiveness in treating multiple manifestations of psoriatic disease was also important The number of injections per dose and injection frequency were least imp
If drugs are to enter the body painlessly and efficiently, they can be administered via skin patches.
Using biosensors to deliver personalized doses of antibiotics
A team of eight EPFL students won the technical prize in the SensUs international competition, designing a portable biosensor that can measure the amount of vancomycin in a patient's blood stream, enabling doctors to better control the dosage and reduce harmful side effects.
A team of eight EPFL students won the technical prize in the SensUs international competition, designing a portable biosensor that can measure the amount of vancomycin in a patient's blood stream, enabling doctors to better control the dosage and reduce harmful side effects.
Empa scientists are saving iron bridges from the 19th century from collapse. Carbon fiber plasters are strengthening the crumbling structures. A railway bridge in Switzerland and a road bridge in Australia have already been reinforced successfully. Many historical bridges could follow. «Partners in crime» are specialists for steel fatigue at EPFL.
Today ETH Zurich celebrated the laying of the foundation stone for its new building on the Schällemätteli campus in Basel.
A team of EPFL students will take part in the Swiss Train Challenge this Friday. The goal is to set foot in each of Switzerland's 26 cantons in less than 24 hours - relying solely on the country's public transport network.
Roche to present new data from its extensive lung cancer programme at the 2018 World Conference on Lung Cancer (WCLC)
Unsere Webseite verwendet Cookies, um Ihnen einen optimalen Service zu bieten. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden.
Unsere Webseite verwendet Cookies, um Ihnen einen optimalen Service zu bieten. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden.
» Comment on this page.